SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-21-013611
Filing Date
2021-12-29
Accepted
2021-12-29 15:51:57
Documents
22
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F form20f.htm   iXBRL 20-F 1624242
2 EXHIBIT 2.2 exhibit2-2.htm EX-2.2 8650
3 EXHIBIT 8.1 exhibit8-1.htm EX-8.1 2331
4 EXHIBIT 12.1 exhibit12-1.htm EX-12.1 12096
5 EXHIBIT 12.2 exhibit12-2.htm EX-12.2 12184
6 EXHIBIT 13.1 exhibit13-1.htm EX-13.1 7475
11 GRAPHIC form20fxz001.jpg GRAPHIC 42439
12 GRAPHIC form20fxz002.jpg GRAPHIC 41482
13 GRAPHIC form20fxz003.jpg GRAPHIC 19606
14 GRAPHIC form20fxz004.jpg GRAPHIC 14594
  Complete submission text file 0001062993-21-013611.txt   2405775

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drug-20210930.xsd EX-101.SCH 4966
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drug-20210930_def.xml EX-101.DEF 20195
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drug-20210930_lab.xml EX-101.LAB 28591
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drug-20210930_pre.xml EX-101.PRE 22877
16 EXTRACTED XBRL INSTANCE DOCUMENT form20f_htm.xml XML 7978
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-40997 | Film No.: 211528759
SIC: 2834 Pharmaceutical Preparations